Overview

Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

Status:
Recruiting
Trial end date:
2022-12-11
Target enrollment:
0
Participant gender:
All
Summary
propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Midazolam
Propofol
Criteria
Inclusion Criteria:

- Liver cirrhosis

- presented to colonoscopy

Exclusion Criteria:

- Encephalopathy

- Hypersensitivity

- Coagulopathy